MedPath

Trial of An Innovative Smartphone Intervention for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking
Interventions
Behavioral: Smartphone-delivered Intervention (SmartQuit)
Registration Number
NCT02724462
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2503
Inclusion Criteria
  • age 18 or older
  • smokes at least five cigarettes daily for at least past 12 months
  • wants to quit cigarette smoking in the next 30 days
  • if concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
  • interested in learning skills to quit smoking
  • willing to be randomly assigned to either condition
  • resides in US
  • has at least daily access to their own personal Apple iPhone, Android, or Windows Phone
  • knows how to login and download a smartphone application
  • willing and able to read in English
  • not using other smoking cessation interventions (including apps or our other intervention studies).
  • willing to complete all three follow-up surveys
  • provide email, phone, and mailing address.
Exclusion Criteria
  • The exclusion criteria are opposite of the inclusion criteria listed above.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalSmartphone-delivered Intervention (SmartQuit)This is the experimental arm of the study. This includes receiving the novel/experimental smartphone smoking cessation app. Therapy description withheld to protect the integrity of the study.
Primary Outcome Measures
NameTimeMethod
30-day Point Prevalence Abstinence, Complete-case12 months post randomization

Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are excluded for the complete-case analysis. Exact 2-sided CI was based on the observed proportion of participants.

Secondary Outcome Measures
NameTimeMethod
30-day Point Prevalence Abstinence, Missing=Smoking Imputation12 months post randomization

Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are imputed as still smoking. Exact 2-sided CI was based on the observed proportion of participants.

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath